Insights and Interventions in Acute Migraine Treatment
Webcast
0.75 AMA PRA Category 1 Credit™ OVERVIEW
Insights and Interventions in Acute Migraine Treatment is organized by Healio, Partners for Advancing Clinical Education (PACE).
Release Date: August 7, 2023
Expiration Date: August 7, 2024
Program Overview:
Whereas the full spectrum of recent advances in the management of migraine is an important consideration for individuals who suffer from this condition, expanded treatment options are particularly important for acute migraine treatment because all migraine patients can benefit from them. This activity reviews new therapeutic options for acute migraine treatment, including new drug classes and novel delivery options for established drug classes.
Educational Objectives:
Upon completion of this activity, participants should be able to:
- Identify gaps in the quality of acute care provided to patients with migraine, the impact on patient quality of life, and opportunities to improve outcomes
- Evaluate new migraine-specific therapies for acute migraine treatment for appropriate patients
ACCREDITATION & CREDITS
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Miller Medical Communications, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education:
PACE designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
TARGET AUDIENCE
PhysicianHealthcare ProfessionalsNeurologistsSPECIALITIES
Neurology
Quick Links